All articles tagged with #regulatory policy
The FDA unveiled a new plausible mechanism pathway to approve medicines crafted for patients’ individual mutations, moving the idea from preview into formal policy and potentially enabling gene-editing–based and other targeted therapies for rare diseases.
Poland barred Chinese-made vehicles from entering military facilities over concerns their onboard sensors could collect sensitive data, with access allowed only if certain functions are disabled and safeguards are met, and it banned linking company phones to infotainment systems in these vehicles, though publicly accessible sites are exempt, aligning with NATO-style defense protections.
India will immediately reduce import duties on high-end European cars to 30% from up to 110% under a new EU trade deal, with price-based caps and annual import quotas that together lift total allowed imports to 160,000 vehicles over 10 years; EVs priced above 20,000 euros will also see cuts, eventually reaching 10% over five years, while domestic EV makers like Tata and Mahindra remain protected for now. The move is expected to boost luxury-car availability and technology transfer for brands such as BMW, Mercedes-Benz, VW, Renault and Stellantis, though price reductions may not be immediate.
As President Trump's deadline for a cap on credit card interest rates approaches, banks say they have many questions and few answers about how the cap would be implemented and its potential effects on lending.
Despite initial opposition, major tech companies have successfully secured favorable policies from President Trump, allowing industry growth and reducing regulatory pressures, which has raised concerns among some conservatives.
Governor Bowman discussed proposed changes to bank capital rules in the United States, emphasizing the need to carefully consider the impact of increased capital requirements on U.S. businesses and the economy. She highlighted concerns about over-calibration and the lack of regulatory tailoring in the proposal, and suggested modifications to mitigate these issues. Bowman also addressed technical areas of change, such as diversification benefits, market risk capital rule calibration, and alignment of risk weights and credit risk. She emphasized the importance of balancing the benefits and costs of capital requirements and the need to consider broader regulatory implications and international comparability.